Redox priming promotes Aurora A activation during mitosis
Abstract
Cell cycle–dependent redox changes can mediate transient covalent modifications of cysteine thiols to modulate the activities of regulatory kinases and phosphatases. Our previously reported finding that protein cysteine oxidation is increased during mitosis relative to other cell cycle phases suggests that redox modifications could play prominent roles in regulating mitotic processes. The Aurora family of kinases and their downstream targets are key components of the cellular machinery that ensures the proper execution of mitosis and the accurate segregation of chromosomes to daughter cells. In this study, x-ray crystal structures of the Aurora A kinase domain delineate redox-sensitive cysteine residues that, upon covalent modification, can allosterically regulate kinase activity and oligomerization state. We showed in both Xenopus laevis egg extracts and mammalian cells that a conserved cysteine residue within the Aurora A activation loop is crucial for Aurora A activation by autophosphorylation. We further showed that covalent disulfide adducts of this residue promote autophosphorylation of the Aurora A kinase domain. These findings reveal a potential mechanistic link between Aurora A activation and changes in the intracellular redox state during mitosis and provide insights into how novel small-molecule inhibitors may be developed to target specific subpopulations of Aurora A.
Additional Information
© 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. This is an article distributed under the terms of the Science Journals Default License. Submitted 10 March 2020; Accepted 1 July 2020; Published 21 July 2020. We thank R. A. Grant, G. J. Dodge, and B. Imperiali (Massachusetts Institute of Technology) for assistance with shipping of the crystals and for help with the synchrotron data collection. We thank M. J. Eck and J. Genova (Dana-Farber Cancer Institute) for use of x-ray facilities and for assistance with data collection, J. C. Walter (Harvard Medical School) for providing laboratory facilities and advice, and B. Alhoch (California Institute of Technology) for assisting with the preparation of some of the Xenopus egg extract. We thank A. Koehler (Massachusetts Institute of Technology, Broad Institute of Harvard and MIT) and T. Lewis (Broad Institute of Harvard and MIT) for initiating the Aurora A inhibitor studies that led up to this work and H. Hayakawa and K. Munger (Brigham and Women's Hospital and Harvard Medical School) for providing a human Aurora A cDNA construct. We would also like to thank J. Patterson, B. van de Kooij, B. Joughin, and P. Creixell (Yaffe laboratory, MIT) for helpful discussions. We thank the Koch Institute's Robert A. Swanson (1969) Biotechnology Center for technical support, specifically G. Paradis, M. Jennings, M. Griffin, and M. Saturno-Condon (flow cytometry) and R. Cook, A. Leshinsky, and R. P. Schiavoni (biopolymers and proteomics). This work was supported by NIH grants R01-ES015339, R35-ES028374, R01-GM104047, and R21-ES020466 to M.B.Y., the Charles and Marjorie Holloway Foundation, and the MIT Center for Precision Cancer Medicine. This work was supported, in part, by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute. Support for this research was provided by a core center grant P30-ES002109 from the National Institute of Environmental Health Sciences, NIH. D.C.L. was also supported by a Merck-MIT Biology postdoctoral fellowship. Work from the Wells lab was supported by R01 CA191018. A.K. and W.G.D were supported by the NIH grant GM043974. This work is based on research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the NIH (P30 GM124165). The Eiger 16M detector on 24-ID-E beam line is funded by a NIH-ORIP HEI grant (S10OD021527). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. Author contributions: D.C.L., M.B.Y., V.J., T.J.R., and J.A.W. designed the experiments. D.C.L., V.J., A.K., and T.J.R. performed the experiments. D.C.L., M.B.Y., V.J., T.J.R., J.A.W., and W.G.D. performed the data processing, analysis, and interpretation. The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper or the Supplementary Materials. The structures and x-ray data have been deposited to the PDB; accession codes are listed in table S2. The raw mass spectrometry data are deposited in the MassIVE repository as dataset MSV000085641 (ftp://massive.ucsd.edu/MSV000085641/).Attached Files
Accepted Version - nihms-1631444.pdf
Supplemental Material - abb6707_Data_file_S1.xlsx
Supplemental Material - abb6707_SM.pdf
Files
Additional details
- PMCID
- PMC8514121
- Eprint ID
- 104501
- Resolver ID
- CaltechAUTHORS:20200722-091504306
- NIH
- R01-ES015339
- NIH
- R35-ES028374
- NIH
- R01-GM104047
- NIH
- R21-ES020466
- Charles and Marjorie Holloway Foundation
- Massachusetts Institute of Technology (MIT)
- NIH
- P30-CA14051
- NIH
- P30-ES002109
- Merck
- NIH
- R01-CA191018
- NIH
- GM043974
- NIH
- P30 GM124165
- NIH
- S10OD021527
- Department of Energy (DOE)
- DE-AC02-06CH11357
- National Cancer Institute
- National Institute of Environmental Health Sciences
- Created
-
2020-07-22Created from EPrint's datestamp field
- Updated
-
2021-11-16Created from EPrint's last_modified field
- Caltech groups
- Division of Biology and Biological Engineering, Division of Biology and Biological Engineering